Phase I/II study of gemcitabine plus vinorelbine in non-small cell lung cancer.
Esteban E, Fra J, Corral N, Valle M, Carrasco J, Sala M, Puerta J, Estrada E, Palacio I, Vieitez JM, Buesa JM, Lacave AJ.
Esteban E, et al. Among authors: palacio i.
Invest New Drugs. 2002 Feb;20(1):73-82. doi: 10.1023/a:1014490417342.
Invest New Drugs. 2002.
PMID: 12003196
Clinical Trial.